Loading...

Medical Innovation Holdings

OTCPK:MIHI
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
MIHI
OTCPK
$634K
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Medical Innovation Holdings, Inc. focuses on establishing a multi-disciplinary medical specialist provider/practice network to serve rural patient population through telemedicine program. The last earnings update was 462 days ago. More info.


Add to Portfolio Compare Print
  • Medical Innovation Holdings has significant price volatility in the past 3 months.
MIHI Share Price and Events
7 Day Returns
-4.5%
OTCPK:MIHI
1.7%
US Healthcare
2.2%
US Market
1 Year Returns
-46.3%
OTCPK:MIHI
-2.1%
US Healthcare
3.8%
US Market
MIHI Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Medical Innovation Holdings (MIHI) -4.5% 37.6% -18.2% -46.3% -98.8% -
US Healthcare 1.7% 3.6% 1.5% -2.1% 26.1% 64.7%
US Market 2.2% 4.2% 4.4% 3.8% 43% 40.9%
1 Year Return vs Industry and Market
  • MIHI underperformed the Healthcare industry which returned -2.1% over the past year.
  • MIHI underperformed the Market in United States of America which returned 3.8% over the past year.
Price Volatility
MIHI
Industry
5yr Volatility vs Market

Value

 Is Medical Innovation Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.

In this section, we usually try to help investors determine whether Medical Innovation Holdings is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Medical Innovation Holdings has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis. You can see them here.

Show me the analysis anyway

INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Medical Innovation Holdings. This is due to cash flow or dividend data being unavailable. The share price is $0.0139.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Medical Innovation Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Medical Innovation Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:MIHI PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-01-31) in USD $-0.04
OTCPK:MIHI Share Price ** OTCPK (2019-06-21) in USD $0.01
United States of America Healthcare Industry PE Ratio Median Figure of 57 Publicly-Listed Healthcare Companies 21.18x
United States of America Market PE Ratio Median Figure of 3,094 Publicly-Listed Companies 17.87x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Medical Innovation Holdings.

OTCPK:MIHI PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OTCPK:MIHI Share Price ÷ EPS (both in USD)

= 0.01 ÷ -0.04

-0.39x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Medical Innovation Holdings is loss making, we can't compare its value to the US Healthcare industry average.
  • Medical Innovation Holdings is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Medical Innovation Holdings's expected growth come at a high price?
Raw Data
OTCPK:MIHI PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.39x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Healthcare Industry PEG Ratio Median Figure of 43 Publicly-Listed Healthcare Companies 1.68x
United States of America Market PEG Ratio Median Figure of 2,134 Publicly-Listed Companies 1.54x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Medical Innovation Holdings, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Medical Innovation Holdings's assets?
Raw Data
OTCPK:MIHI PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-01-31) in USD $-0.04
OTCPK:MIHI Share Price * OTCPK (2019-06-21) in USD $0.01
United States of America Healthcare Industry PB Ratio Median Figure of 94 Publicly-Listed Healthcare Companies 2.45x
United States of America Market PB Ratio Median Figure of 5,255 Publicly-Listed Companies 1.81x
OTCPK:MIHI PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OTCPK:MIHI Share Price ÷ Book Value per Share (both in USD)

= 0.01 ÷ -0.04

-0.35x

* Primary Listing of Medical Innovation Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Medical Innovation Holdings has negative assets, we can't compare the value of its assets to the US Healthcare industry average.
X
Value checks
We assess Medical Innovation Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Medical Innovation Holdings has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Medical Innovation Holdings expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medical Innovation Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
12.4%
Expected Healthcare industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Medical Innovation Holdings expected to grow at an attractive rate?
  • Unable to compare Medical Innovation Holdings's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Medical Innovation Holdings's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare Medical Innovation Holdings's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:MIHI Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 12.4%
United States of America Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 6.2%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:MIHI Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 year ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:MIHI Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-01-31 0 0 -1
2017-10-31 0 0 -1
2017-07-31 0 -1
2017-04-30 0 -1
2016-04-30 0 -1

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Medical Innovation Holdings is high growth as no earnings estimate data is available.
  • Unable to determine if Medical Innovation Holdings is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:MIHI Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 year ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Medical Innovation Holdings Company Filings, last reported 1 year ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:MIHI Past Financials Data
Date (Data in USD Millions) EPS *
2018-01-31 -0.04
2017-10-31 -0.03
2017-07-31 -0.03
2017-04-30 -0.02
2016-04-30 -0.02

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Medical Innovation Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Medical Innovation Holdings's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  2. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Medical Innovation Holdings's filings and announcements here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Medical Innovation Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Medical Innovation Holdings has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Medical Innovation Holdings performed over the past 5 years?

  • Medical Innovation Holdings's last earnings update was 462 days ago.
The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Medical Innovation Holdings's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Medical Innovation Holdings does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare Medical Innovation Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Medical Innovation Holdings's 1-year growth to the US Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
Medical Innovation Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Medical Innovation Holdings Company Filings, last reported 1 year ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:MIHI Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-01-31 0.05 -1.43 0.92
2017-10-31 0.05 -1.19 0.95
2017-07-31 -1.00 0.77
2017-04-30 -0.90 0.84
2016-04-30 -0.66

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Medical Innovation Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
  • It is difficult to establish if Medical Innovation Holdings has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Medical Innovation Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.
X
Past performance checks
We assess Medical Innovation Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Medical Innovation Holdings has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Medical Innovation Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Medical Innovation Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Medical Innovation Holdings's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Medical Innovation Holdings has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Medical Innovation Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Medical Innovation Holdings has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Medical Innovation Holdings Company Filings, last reported 1 year ago.

OTCPK:MIHI Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-01-31 -1.56 0.51 0.01
2017-10-31 -1.51 0.63 0.10
2017-07-31 -1.32 0.34 0.03
2017-04-30 -1.12 0.32 0.01
2016-04-30 -0.66 0.46 0.00
  • Medical Innovation Holdings has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
  • Irrelevant to check if Medical Innovation Holdings's debt level has increased considering it has negative shareholder equity.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Medical Innovation Holdings has less than a year of cash runway based on current free cash flow.
  • Medical Innovation Holdings has less than a year of cash runway if free cash flow continues to grow at historical rates of 80% each year.
X
Financial health checks
We assess Medical Innovation Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Medical Innovation Holdings has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Medical Innovation Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Medical Innovation Holdings dividends.
If you bought $2,000 of Medical Innovation Holdings shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Medical Innovation Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Medical Innovation Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:MIHI Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 21 Stocks 1.6%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2012 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Medical Innovation Holdings has not reported any payouts.
  • Unable to verify if Medical Innovation Holdings's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Medical Innovation Holdings's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Medical Innovation Holdings has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Medical Innovation Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Medical Innovation Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Medical Innovation Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Medical Innovation Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Redgie Green
AGE 64
TENURE AS CEO 0.1 years
CEO Bio

Mr. Reginald T. Green, also known as Redgie, has been an Interim Chief Executive Officer of Medical Innovation Holdings, Inc. since May 7, 2019. Mr. Green has been the Chief Executive Officer of Momentum Biofuels, Inc. since May 2012. Mr. Green has been President of Asiana Dragons Inc. since April 26, 2011 and serves as its Chief Executive Officer and Chief Financial Officer. He serves as the Chief Executive Officer of Legacy Technology Holdings, Inc. Mr. Green serves as a Director at Medical Innovation Holdings, Inc., since February 05, 2019. Mr. Green has been Co-owner and Operator of Green's B&R Enterprises, a wholesale donut baker since 1983. He serves as the President of Greenhouse Solutions Inc. and served as its Acting Chief Executive Officer since November 26, 2014. Mr. Green served as the Chief Executive Officer of Sun River Energy Inc. until August 3, 2010 and its Secretary since 1999. Mr. Green served as Principal Accounting Officer and Treasurer of Sun River Energy, Inc. Mr. Green served as the President of Sun River Energy Inc. from January 8, 2009 to July 2010. Mr. Green served as Secretary and Treasurer of Cap Tech Financial Group Inc. since April 29, 2006. He served as Treasurer of Quikbyte Software, Inc. Mr. Green has been an active investor in small capital and high tech adventures since 1987. He served as Secretary and Treasurer of Mountains West Exploration Inc. from November 2004 to 2005 and of Naerodynamics, Inc. (a/k/a Health Partnership Inc.) since January 1, 2005. He served as Acting Chief Financial Officer, Acting Chief Accounting Officer and Director of Legacy Technology Holdings, Inc. He served as Secretary and Treasurer of Baymark Technologies, Inc. He served as Secretary of Quikbyte Software, Inc. and Houston Operating Company. He served as Treasurer of Dynadapt System Inc. and served as its Secretary since 1998. He served as Treasurer and Secretary of Performing Brands, Inc. He served as Treasurer and Secretary of Secured Digital Storage Corp. until 2005. He has been a Director of Asiana Dragons, Inc. since April 26, 2011 and Momentum Biofuels, Inc. since May 2012. He had served as a Director of International Paintball Association, Inc. since March 2006 until 2012. He has been a Director of Greenhouse Solutions Inc. since November 26, 2014. He serves as a Director of Mind2Market Inc. He had served as a Director of Golden Dragon Holding Co. from March 2006 to May 9, 2014. Mr. Green was a director and officer of Fuquan Financial Co (fka Southwestern Water Exploration, Inc.) February 2017 through March 7, 2018. He served as a Director of CapTech Financial Group Inc. since April 29, 2006 and Quikbyte Software, Inc. since February 20, 2007. He served as a Director of Sun River Energy, Inc. since 1999. He served as Director of ASPI, Inc. from March 13, 2006 to November 2, 2009. He served as a Director of INTREorg Systems Inc. from March 2008 to October 11, 2017. He served as Director of Mountains West Exploration, Inc. from November 2004 to December 19, 2005. He served as Director of Baymark Technologies, Inc. from 2005 to 2006. He served as Director of CannaPharmaRX, Inc. until May 31, 2014. He served as a Director of JV Group, Inc. until November 02, 2009. He served as Director of Naerodynamics, Inc. He served as a Director of Kimbell Decar Corp. He served as a Director of Dynadapt Systems Inc. since 1998. He served as Director of Colorado Gold & Silver Inc. since 2000 and Houston Operating Company from 2004 to December 2004. He served as Director of Health Partnership Inc. and Paradigm Holdings Inc. (Formerly, Cheyenne Resources Inc.). He served as a Director of Performing Brands, Inc. He served as Director of Cap Tech Financial Group Inc. since April 29, 2006. He served as a Director of Secured Digital Storage Corp. until 2005. Mr. Green holds a Bachelor of Arts Degree in Computer Information Systems from Tarleton State University.

CEO Compensation
  • Insufficient data for Redgie to compare compensation growth.
  • Insufficient data for Redgie to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Medical Innovation Holdings management team in years:

0.3
Average Tenure
61
Average Age
  • The average tenure for the Medical Innovation Holdings management team is less than 2 years, this suggests a new team.
Management Team

Redgie Green

TITLE
Interim CEO & Director
AGE
64
TENURE
0.1 yrs

Ray DeMotte

TITLE
CFO & Director
AGE
61
TENURE
0.3 yrs

Kevin Swint

TITLE
Chief Operating Officer
TENURE
1.8 yrs

Christopher Leggett

TITLE
Chief Medical Officer
AGE
57
Board of Directors Tenure

Average tenure and age of the Medical Innovation Holdings board of directors in years:

0.3
Average Tenure
61
Average Age
  • The average tenure for the Medical Innovation Holdings board of directors is less than 3 years, this suggests a new board.
Board of Directors

Redgie Green

TITLE
Interim CEO & Director
AGE
64
TENURE
0.3 yrs

Ray DeMotte

TITLE
CFO & Director
AGE
61
TENURE
0.3 yrs

John Stol

TITLE
Director
AGE
53
TENURE
3.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Medical Innovation Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Medical Innovation Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Medical Innovation Holdings, Inc. focuses on establishing a multi-disciplinary medical specialist provider/practice network to serve rural patient population through telemedicine program. Its integrated practice management system provides electronic medical records/electronic health records, patient scheduling, real time insurance verification, billing, video conferencing, and various systems in an end to end technology platform coupled with the components of a telehealth delivery system. The company is based in Duluth, Georgia.

Details
Name: Medical Innovation Holdings, Inc.
MIHI
Exchange: OTCPK
Founded:
$633,955
45,608,275
Website: http://medicalinnovationholdings.com
Address: Medical Innovation Holdings, Inc.
5805 State Bridge Road,
Suite G-328,
Duluth,
Georgia, 30097,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OTCPK MIHI Common Stock Pink Sheets LLC US USD 02. May 2016
Number of employees
Current staff
Staff numbers
0
Medical Innovation Holdings employees.
Industry
Managed Health Care
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/24 00:00
End of day share price update: 2019/06/21 00:00
Last earnings filing: 2018/03/19
Last earnings reported: 2018/01/31
Last annual earnings reported: 2017/04/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.